Postgraduate Course

Session 1B: Complex Issues in Inflammatory Bowel Disease

Session 1B: Complex Issues in Inflammatory Bowel Disease

Saturday, October 14
10:30 AM - 12:10 PM
Location: Valencia Ballroom (Level 4)

Category: IBD

Uma Mahadevan

Professor of Clinical Medicine, University of California San Francisco; Co-Medical Director
University of California, San Francisco
San Francisco, CA

Dr. Uma Mahadevan completed a medical degree at State University of New York in Brooklyn. She completed residency in internal medicine at Mount Sinai Medical Center, New York, gastroenterology fellowship at the University of California, San Francisco (UCSF) and fellowship in inflammatory bowel disease (IBD) at Mayo Clinic, Rochester, Minnesota. Dr. Mahadevan currently serves as Professor of Medicine at UCSF and Medical Director of the UCSF Center for Colitis and Crohn's Disease. Certified by the ABIM as a Diplomate in internal medicine and gastroenterology, Dr. Mahadevan is a Fellow of the ACG and the AGA, for whom she is a Councilor for the IMIBD Section. She is a section editor for the journal Gastroenterology. She is currently co-Chair of the research affairs committee of the Crohn's and Colitis Foundation of America and was formerly Chairman of the National Patient Education Committe, as well as Director of Patient Education for WE CARE, an organization of women professionals in IBD. She also served as President of the Northern California Society of Clinical Gastroenterology in 2005. Dr. Mahadevan has published original articles, abstracts, editorials, and invited reviews in such peer-reviewed journals as Gastroenterology, The American Journal of Gastroenterology, Inflammatory Bowel Diseases, and Gut, along with several book chapters. Additionally, Dr. Mahadevan is an editorial board member and reviewer for several journals. Dr. Mahadevan specializes in the treatment of ulcerative colitis, Crohn's disease, and pouchitis. She has a particular interest in pregnancy and fertility in IBD, as well as in clinical trials of experimental therapy for both ulcerative colitis and Crohn's disease. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO), clinical trials in biologic therapy for IBD, and microbiome, environmental and dietary changes among South Asians with IBD.

Presentation(s):

Send Email for Uma Mahadevan

Gerhard Rogler

Professor
University Hospital Zurich
Zurich, Not Applicable, Switzerland

Gerhard Rogler received his approbation as physician and MD degree from the University of Ulm, Germany, in 1992, and his PhD degree after studying philosophy in Ulm and Augsburg, Germany, in 1996. After an internship (Dept. of Internal Medicine II, University of Ulm) from 1991 to 1992, he was a postdoctoral fellow at the Institute of Clinical Chemistry and Pathobiochemistry, University of Regensburg between 1992 and 1994. In 1994 he changed to the Department of Internal Medicine I, University of Regensburg (Director Prof. Dr. Jürgen Schölmerich) to work as a clinical and research fellow. After receiving his Internal Medicine Boards in 1999, Gerhard Rogler became attending physician and senior lecturer. In 1999 he received a prestigious Heisenberg Award of the Deutsche Forschungsgemeinschaft. From 2000 to 2001 Gerhard Rogler was Visiting Scholar at the Center of Molecular Medicine, University of San Diego, San Diego, California. In 2003 Gerhard Rogler became Associate Professor and head of the Div. of Gastroenterology and Hepatology at the University of Regensburg, Germany. Since 2007 he has been a full Professor of Gastroenterology and Hepatology at the University of Zurich. He has built up a center for IBD treatment and research. His fields of research are mucosal inflammation, innate immunity, IBD, intestinal fibrosis, inflammation-associated colon cancer, GvHD. Gerhard Rogler has published more than 450 PubMed-listed manuscripts with a cumulative impact factor of > 3000, has more than 15.000 citations and a h-index of 63. He received numerous awards such as the "Honorary Award 2013" of the Swiss Gastroenterology Society, SGG, and the honorary membership of the South African Society of Gastroenterology in 2013. Gerhard Rogler is member of the Governing Board of the European Crohn's and Colitis Organization (ECCO) and member of the International Organization of IBD Research (IOIBD).

Presentation(s):

Send Email for Gerhard Rogler


Assets

Session 1B: Complex Issues in Inflammatory Bowel Disease



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Session 1B: Complex Issues in Inflammatory Bowel Disease